Contact
searchSearch
HMP Global

November 2017 - FRMC

Column

Viewpoint
Selling Health Insurance Across State Lines Is Not the Change We Need
11/28/2017
Greg Borca
Greg Borca, co-founder of SKYGEN USA, discusses the future competition that will enable full coverage and drive down costs following President Donald Trump's executive order to allow health insurance to be sold across state lines.
Greg Borca, co-founder of SKYGEN USA, discusses the future competition that will enable full coverage and drive down costs following President Donald Trump's executive order to allow health insurance to be sold across state lines.
Greg Borca, co-founder of SKYGEN...
11/28/2017
First Report Managed Care
Viewpoint
Reducing the Burden of Cardiovascular Disease with Precision Medicine
11/28/2017
Jim Cross
Jim Cross, former Vice President and Head of National Medical Policy and Operations, Aetna, discusses how precision medicine is the new and emerging approach to treating patients cardiovascular disease.
Jim Cross, former Vice President and Head of National Medical Policy and Operations, Aetna, discusses how precision medicine is the new and emerging approach to treating patients cardiovascular disease.
Jim Cross, former Vice President...
11/28/2017
First Report Managed Care

Department

Formulary Frontlines®
Formulary Decisions For HIV Prevention: Pre-Exposure Prophylaxis
11/28/2017
Julia Jarmoszko, PharmD, MBA
Julia Jarmoszko, PharmD, discusses how PrEP is an effective preventative HIV measure that should be available for individuals at high risk of acquiring the virus.
Julia Jarmoszko, PharmD, discusses how PrEP is an effective preventative HIV measure that should be available for individuals at high risk of acquiring the virus.
Julia Jarmoszko, PharmD,...
11/28/2017
First Report Managed Care
Conference Insider
Pradaxa Shows Added Cost Benefits Compared to Warfarin, Xarelto
11/27/2017
A poster presentation at AMCP Nexus 2017 compared Pradaxa (dabigatran; Boehringer Ingelheim) to warfarin and Xarelto (rivaroxaban; Janssen) for prevention of stroke and bleed-related hospitalization, and costs. 
A poster presentation at AMCP Nexus 2017 compared Pradaxa (dabigatran; Boehringer Ingelheim) to warfarin and Xarelto (rivaroxaban; Janssen) for prevention of stroke and bleed-related hospitalization, and costs. 
A poster presentation at AMCP...
11/27/2017
First Report Managed Care
Conference Insider
Short-Acting Beta-Agonist Inhalers Reduce COPD Budget Impact
11/27/2017
A poster at AMCP Nexus 2017 found that use of short-acting beta-agonist inhalers with an integrated dose counter could reduce the budget impact of COPD.
A poster at AMCP Nexus 2017 found that use of short-acting beta-agonist inhalers with an integrated dose counter could reduce the budget impact of COPD.
A poster at AMCP Nexus 2017...
11/27/2017
First Report Managed Care
Conference Insider
Medicare Patients With Diabetes Incur Significantly Higher Costs Due to CVD Death
11/27/2017
Patients with diabetes who died as a result of comorbid cardiovascular disease incurred significantly higher direct costs before their death, according to a recent poster presentation at AMCP Nexus 2017.
Patients with diabetes who died as a result of comorbid cardiovascular disease incurred significantly higher direct costs before their death, according to a recent poster presentation at AMCP Nexus 2017.
Patients with diabetes who died...
11/27/2017
First Report Managed Care
Conference Insider
Value-Based Care for Diabetes Does Not Increase Costs
11/27/2017
A poster presented at AMCP Nexus 2017 found that implementation of a value-based plan design did not significantly impact costs compared to standard benefit design. 
A poster presented at AMCP Nexus 2017 found that implementation of a value-based plan design did not significantly impact costs compared to standard benefit design. 
A poster presented at AMCP Nexus...
11/27/2017
First Report Managed Care
Conference Insider
Opioid Management Program Helped Cut Misuse Among Medicaid Enrollees
11/27/2017
According to a poster presentation at AMCP Nexus 2017, a managed care pharmacy program tailored to Medicaid members helped to cut opioid utilization.
According to a poster presentation at AMCP Nexus 2017, a managed care pharmacy program tailored to Medicaid members helped to cut opioid utilization.
According to a poster...
11/27/2017
First Report Managed Care
Conference Insider
Switching Biologics Could Increase Costs
11/27/2017
A poster presented at AMCP Nexus 2017 found that switching biologic products was associated with greater health care costs among patients with rheumatoid arthritis. 
A poster presented at AMCP Nexus 2017 found that switching biologic products was associated with greater health care costs among patients with rheumatoid arthritis. 
A poster presented at AMCP Nexus...
11/27/2017
First Report Managed Care
Conference Insider
Breaking Down the Current State of the ACA
11/27/2017
Melissa Andel, MPP, director of health policy at Applied Policy outlined the most up to date policy changes that could impact how insurers participate in ACA marketplaces in 2018.
Melissa Andel, MPP, director of health policy at Applied Policy outlined the most up to date policy changes that could impact how insurers participate in ACA marketplaces in 2018.
Melissa Andel, MPP, director of...
11/27/2017
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Long-Wave Infrared Thermography Helps LTACH Achieve Pressure Injury Success
04/25/2023
Jolynn Tumolo
“The LTACH facility maintained a zero hospital-acquired pressure injury rate for 10 months after implementation of long-wave infrared thermography," researchers reported.
“The LTACH facility maintained a zero hospital-acquired pressure injury rate for 10 months after implementation of long-wave infrared thermography," researchers reported.
“The LTACH facility maintained a...
04/25/2023
First Report Managed Care
Headshot of Barbara Konkle, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Discussing a Novel Factor VIII Replacement Therapy for Patients With Hemophilia
05/24/2023
Maria Asimopoulos
Barbara Konkle, MD, professor of medicine, Division of Hematology, University of Washington; research director, Washington Center for Bleeding Disorders; and director, Hemostasis, Platelet Immunology and Genomics Laboratory at Bloodworks...
Barbara Konkle, MD, professor of medicine, Division of Hematology, University of Washington; research director, Washington Center for Bleeding Disorders; and director, Hemostasis, Platelet Immunology and Genomics Laboratory at Bloodworks...
Barbara Konkle, MD, professor of...
05/24/2023
First Report Managed Care
Formulary Frontlines®
Challenges, Treatment Options, and Costs Linked With Upper Tract Urothelial Carcinoma
06/20/2023
Julie Gould
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth...
06/20/2023
First Report Managed Care
News
Medicare Could Save $1 Billion by Considering Added Benefit of Expensive Part B Drugs
07/18/2023
Jolynn Tumolo
Researchers find that Medicare could potentially save $1 billion by considering the added therapeutic benefit of expensive Part B drugs and implementing reference pricing.
Researchers find that Medicare could potentially save $1 billion by considering the added therapeutic benefit of expensive Part B drugs and implementing reference pricing.
Researchers find that Medicare...
07/18/2023
First Report Managed Care
News
New Platform Leverages Real-World Evidence for Type 2 Inflammation Immunological Disease Research
08/07/2023
Hannah Musick
Researchers introduce Immunolab, a platform that generates real-world evidence to provide insights and conduct research on immunological diseases related to type 2 inflammation.
Researchers introduce Immunolab, a platform that generates real-world evidence to provide insights and conduct research on immunological diseases related to type 2 inflammation.
Researchers introduce Immunolab,...
08/07/2023
First Report Managed Care

November 2017 Volume 14 Issue 11

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use